液体蓄积对危重患者主要不良肾脏事件的影响——一项观察性队列研究
该回顾性单中心队列纳入13,326例成年ICU患者,其中1,100例(8.3%)在ICU第3天达到液体蓄积定义(累积液体平衡>体重5%)。液体蓄积与MAKE30显著相关(aOR 1.96;95%CI 1.67-2.30;p<0.001),并与肾脏替代治疗需求(aOR 3.83)、持续性肾功能障碍(aOR 1.72)和30天死亡率(aOR 1.70)各亚组分均相关(p均<0.001)。敏感性分析显示该关联独立于既存CKD,且仅在AKI 3期患者中显著;液体蓄积还与整个观察期肌酐轨迹独立相关。
要点
- ICU第3天液体蓄积定义为累积液体平衡>体重5%,13,326例中1,100例(8.3%)符合。
- 液体蓄积与MAKE30独立相关:aOR 1.96(95%CI 1.67-2.30;p<0.001)。
- 液体蓄积与肾脏替代治疗需求相关最强:aOR 3.83(95%CI 3.02-4.84;p<0.001)。
- 液体蓄积与30天死亡率相关:aOR 1.70(95%CI 1.38-2.09;p<0.001)。
- 敏感性分析显示该关联独立于既存CKD,且仅在AKI 3期患者中显著。
适用人群与场景
- 成年ICU患者,且具备计算液体蓄积和MAKE30的充分数据。
诊断标准与关键阈值
- 液体蓄积定义:ICU第3天累积液体平衡>体重5%。
- MAKE30:ICU入科后30天内主要不良肾脏事件,包括肾脏替代治疗需求、持续性肾功能障碍和30天死亡率。
研究设计与关键结果
- 研究类型:回顾性单中心队列研究;样本量13,326例,其中1,100例(8.3%)符合液体蓄积定义。
- 液体蓄积与MAKE30:aOR 1.96(95%CI 1.67-2.30;p<0.001)。
- 液体蓄积与肾脏替代治疗需求:aOR 3.83(95%CI 3.02-4.84;p<0.001)。
- 液体蓄积与持续性肾功能障碍:aOR 1.72(95%CI 1.40-2.12;p<0.001)。
- 液体蓄积与30天死亡率:aOR 1.70(95%CI 1.38-2.09;p<0.001)。
- 敏感性分析:液体蓄积与MAKE30的关联独立于既存CKD,但仅在AKI 3期患者中显著。
- 液体蓄积与整个观察期肌酐轨迹独立相关。
证据类型、等级与局限
- 证据类型:回顾性单中心观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为液体蓄积与危重患者MAKE30显著相关,该关联独立于既存CKD,且在AKI 3期患者中最强。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Fluid accumulation (FA) is known to be associated with acute kidney injury (AKI) during intensive care unit (ICU) stay but data on mid-term renal outcome is scarce. The aim of this study was to investigate the association between FA at ICU day 3 and major adverse kidney events in the first 30 days after ICU admission (MAKE30).
METHODS: Retrospective, single-center cohort study including adult ICU patients with sufficient data to compute FA and MAKE30. We defined FA as a positive cumulative fluid balance greater than 5% of bodyweight. The association between FA and MAKE30, including its sub-components, as well as the serum creatinine trajectories during ICU stay were examined. In addition, we performed a sensitivity analysis for the stage of AKI and the presence of chronic kidney disease (CKD).
RESULTS: Out of 13,326 included patients, 1,100 (8.3%) met the FA definition. FA at ICU day 3 was significantly associated with MAKE30 (adjusted odds ratio [aOR] 1.96; 95% confidence interval [CI] 1.67-2.30; p < 0.001) and all sub-components: need for renal replacement therapy (aOR 3.83; 95%CI 3.02-4.84), persistent renal dysfunction (aOR 1.72; 95%CI 1.40-2.12), and 30-day mortality (aOR 1.70; 95%CI 1.38-2.09), p all < 0.001. The sensitivity analysis showed an association of FA with MAKE30 independent from a pre-existing CKD, but exclusively in patients with AKI stage 3. Furthermore, FA was independently associated with the creatinine trajectory over the whole observation period.
CONCLUSIONS: Fluid accumulation is significantly associated with MAKE30 in critically ill patients. This association is independent from pre-existing CKD and strongest in patients with AKI stage 3.
参考来源
- Hofer DM, Ruzzante L, Waskowski J, et al. Influence of fluid accumulation on major adverse kidney events in critically ill patients - an observational cohort study. Ann Intensive Care. 2024. PMID: 38587575. doi:10.1186/s13613-024-01281-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。